A

Amylyx Pharmaceuticals

Biopharmaceutical company developing neurodegenerative therapies

Senior Director - CMC Technical Development

Bioprocess & BiomanufacturingPosted on Nov 16
Full-timeRemote in USA

About the Job

Requirements

  • An advanced degree in chemistry, chemical engineering, pharmaceutical sciences, biochemistry, or a related scientific or engineering discipline is required; a Ph.D. is preferred.
  • Strong understanding of small molecule, synthetic peptide, oligonucleotide, RNA, and/or amino acid chemistries and related manufacturing technologies.
  • At least 15 years of progressive pharmaceutical or biotechnology experience in technical development, process development, and late-stage CMC development, including at least 5–8 years in a leadership capacity.
  • Demonstrated expertise developing phase-appropriate processes across modalities from early clinical development through late-stage filing and commercialization.
  • Deep expertise in Quality by Design (QbD) and advanced knowledge of cGMP expectations and relevant FDA, EMA, ICH, and other global CMC guidance and regulatory requirements.
  • Ability to operate independently, influence without direct authority, make sound technical decisions under ambiguity, and build trusted relationships with internal stakeholders and external partners.
  • Excellent leadership, communication, collaboration, technical writing, and executive-level presentation skills.
  • Ability to travel domestically and internationally up to 10%, with additional travel as business needs require.
  • Ability to work remotely in a setting with privacy, reliable internet access, phone service, and video-conferencing capability, and to attend regular meetings at the Cambridge, Massachusetts office.

Responsibilities

  • Lead technical development across the pipeline, ensuring plans are scientifically rigorous, phase-appropriate, and aligned with clinical, regulatory, quality, supply, and business objectives.
  • Serve directly or through direct reports as the Technical Development lead on CMC asset teams, providing technical requirements, risks, timelines, decision options, regulatory filing materials, and clinical supplies.
  • Provide input into target product profiles, assess technical feasibility, and translate requirements into critical quality attributes and critical process parameters.
  • Partner with CMC Team Strategy leads to integrate technical development plans into overall asset strategies.
  • Identify critical path activities, technical risks, resource needs, and budget implications, and develop mitigation plans and contingency strategies with internal and external teams.
  • Lead CDMO evaluation, selection, onboarding, due diligence, technology transfer, and external development or manufacturing campaigns.
  • Travel to global manufacturing and development sites to support technical transfers, GMP campaigns, and troubleshooting.
  • Lead phase-appropriate drug substance and drug product development for clinical and late-stage programs, including formulation and process optimization, scale-up, and process characterization.
  • Establish robust, scalable, reproducible, and cost-effective drug substance and drug product manufacturing processes to support clinical supply, regulatory submissions, and future commercial manufacture.
  • Develop and maintain control strategies and ensure manufacturing processes, specifications, and technical packages are scientifically justified and aligned with global regulatory expectations.
  • Provide technical subject matter expertise through product registration, including technical assessments, development reports, process descriptions, control strategy documentation, and regulatory submission content.
  • Lead technical troubleshooting, deviation investigations, root-cause analyses, CAPAs, change controls, batch record review, and campaign data review with Quality and external partners to support clinical supply.
  • Review and approve clinical CDMO technical documents, including protocols, batch records, campaign plans, development reports, deviation assessments, technical memos, and drug substance and drug product manufacturing documentation.
  • Partner with Regulatory CMC to author, review, and defend technical content for INDs, NDAs, BLAs, MAAs, health authority questions, and briefing materials.
  • Support the MSAT team with PPQ planning and commercial technical readiness by ensuring process understanding, control strategy, comparability, and manufacturing documentation are appropriately developed for late-stage programs approaching filing and launch.
  • Lead, mentor, and develop internal technical development team members and matrixed project leads, fostering scientific rigor, accountability, collaboration, urgency, and pragmatic decision-making.
  • Provide career development guidance, coaching, performance feedback, and succession planning for team members.
  • Allocate resources across programs and align technical development priorities with organizational objectives, program milestones, and available capacity.
  • Build scalable technical development processes, templates, governance routines, and best practices for a growing biotech organization operating through external partners.
  • Promote technical excellence through coaching, training, knowledge sharing, and transparent communication across internal teams and CDMO partners.

Desired Qualifications

  • A strong track record supporting global CMC submissions, health authority interactions, inspection readiness, and successful product approvals.

About the Company

Amylyx Pharmaceuticals

Biopharmaceutical company developing neurodegenerative therapies

Amylyx Pharmaceuticals develops treatments for neurodegenerative diseases, with a focus on ALS and Alzheimer's disease. Its main asset is AMX0035, currently in clinical trials, including the CENTAUR study for ALS and the PEGASUS study for late mild cognitive impairment or early dementia due to Alzheimer’s disease. The company advances products through rigorous, randomized, double-blind, placebo-controlled trials to demonstrate safety and efficacy before pursuing commercialization. In addition to research, Amylyx engages in awareness and community campaigns to support patients, caregivers, and researchers. The company aims to bring validated therapies to market to improve patient outcomes and generate revenue by selling treatments to healthcare providers and patients.

Company size
51-200
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2013

Recently Posted Jobs

Explore more opportunities at Amylyx Pharmaceuticals

See more jobs